Syngene International Ltd Q3 2021 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Alankar Garude - Macquarie Research - Analyst : Sir, my first question is, is there any difference in the nature of conversations you are having with your clients, say, versus what it was in March, April and now? I mean, was there perhaps more urgency then versus what the situation is now? And also, are there, if at all if you could highlight, any structural changes in how clients are thinking about outsourcing, especially to Indian companies?

Question: Alankar Garude - Macquarie Research - Analyst : No, that's really very helpful, Jonathan. So maybe a small follow-up to that would be -- so do you expect this change to be structural? Do you expect this to persist even after COVID, say, maybe 1, 2 years down the line or that there is a scope that clients are looking at this purely from a near-term perspective?

Question: Alankar Garude - Macquarie Research - Analyst : That's helpful, Jonathan. My second question is to Sibaji-sir. Sir, can you quantify the cost pertaining to the Mangalore facility that is currently being reflected in the third quarter? And also if you could tell us if this would be approximately what percentage of the total OpEx for Mangalore once the plant is fully operational?

Question: Alankar Garude - Macquarie Research - Analyst : And broadly, this would be what percentage of the total cost once -- maybe in FY '22, once the plant is fully operational, this would be roughly what percentage of the total cost related to Mangalore, the OpEx cost I'm asking?

Question: Alankar Garude - Macquarie Research - Analyst : Sir, my question is, now the cost which is being attributed to Mangalore as of now, as of the third quarter, approximately what it would be as a percentage of the total OpEx for Mangalore once the plant is completely operational? So essentially, what part of the Mangalore cost is being reflected in the P&L as of now?

Question: Alankar Garude - Macquarie Research - Analyst : Sir, do you want me to...

Question: Alankar Garude - Macquarie Research - Analyst : Yes, sir. You want me to repeat the question, sir?

Question: Alankar Garude - Macquarie Research - Analyst : Okay. So actually, my question was slightly different, but maybe I can take it off-line, sir, no worries.

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : My question pertains to the order book currently. How do you see the order book moving over the next 4 quarters?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Right. Yes. My second question pertains to BMS. BMS has got quite a few approvals over the last 3 months -- 3 to 4 months. Do you see any part of that business coming into Syngene?

Question: Charulata Gaidhani - Dalal & Broacha Stock Broking Pvt Ltd., Research Division - Analyst : Yes.